The Medicines Evaluation Board (MEB) is working to create a strong academic network and effective cooperation with external parties. We are doing this within the framework of the Regulatory Science programme. By cooperating and investing in PhD projects we can develop and validate new standards and instruments for the assessment of medicines and this, in turn, is enabling us to do our regulatory work more efficiently and improve the effectiveness of medicines.

The MEB's scientific programme links up with the 3 domains of the life cycle of medicines:

  • Development and Innovation
  • Regulations and Decision-making
  • Use and Consumer Safety


The MEB collaborates broadly in the field of regulatory science in the Netherlands, within Europe and elsewhere. For example we helped to set up, and are the vice-chair of, the Regulatory Science Network Netherlands (RSNN) and we are involved in projects run by the European Innovative Medicine Initiative. These partnerships are contributing to the high-quality assessment of the efficacy and risks of medicines. In addition, the MEB organises the MEB Science Day every year to bring together representatives from medicine authorities, the care sector, the world of academia and industry

Regulatory Science Magazine

Since September 2017 the MEB has published 3 editions of the Regulatory Science Magazine each year. The magazine will keep you updated on recent highlights of regulatory science and includes interviews, pitches by PhD students and the latest information on scientific events. And it enables the MEB to update chain partners and researchers on current developments within the field of regulatory science.


Various PhD students and other university students are performing research at the MEB. PhD students divide their time between their research and helping to assess medicine dossiers. This creates an excellent link between science and assessment in practice. The Science Committee decides which research the MEB should be involved in and which research projects are eligible for funding and also guarantees scientific quality during the various research procedures.